Implementation of a self-sampling HPV test for non-responders to cervical cancer screening in Japan: secondary analysis of the ACCESS trial

A self-sampling human papillomavirus (HPV) test could improve the morbidity and mortality of cervical cancer in Japan. However, its effectiveness and feasibility have not been demonstrated sufficiently. Hence, we launched a randomized controlled trial, which is ongoing, and report the results of a s...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2022-08, Vol.12 (1), p.14531-14531, Article 14531
Main Authors: Fujita, Misuzu, Nagashima, Kengo, Shimazu, Minobu, Suzuki, Misae, Tauchi, Ichiro, Sakuma, Miwa, Yamamoto, Setsuko, Hanaoka, Hideki, Shozu, Makio, Tsuruoka, Nobuhide, Kasai, Tokuzo, Hata, Akira
Format: Article
Language:English
Subjects:
692/308/174
692/308/2779/777
692/4028/67/1517
692/4028/67/2195
692/4028/67/2322
692/700/478
Cancer screening
Cervical cancer
Cervix
Consent
Human papillomavirus
Humanities and Social Sciences
Medical screening
Morbidity
multidisciplinary
Sampling
Science
Science (multidisciplinary)
Secondary analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A self-sampling human papillomavirus (HPV) test could improve the morbidity and mortality of cervical cancer in Japan. However, its effectiveness and feasibility have not been demonstrated sufficiently. Hence, we launched a randomized controlled trial, which is ongoing, and report the results of a secondary analysis. To ensure autonomous participation with a minimum selection bias, opt-out consent was obtained from women who met the inclusion criteria, and written consent was obtained from those who underwent a self-sampling test. The number of women who met the inclusion criteria was 20,555; 4283 and 1138 opted out before and after the assignment, respectively. Of the 7340 women in the self-sampling arm, 1372 (18.7%) ordered and 1196 (16.3%) underwent the test. Younger women in their 30 s and 40 s tended to undertake the test more frequently than older women in their 50 s ( P for trend 
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-022-18800-w